Pro Dex Inc 's ability to collect accounts receivable sequentially worsen to 4.12, indicating more challenging environment then in the third quarter 2026, but still, it is a far cry from any concerns. Pro Dex Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 89 days, from 86 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 77 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 161 to 740.

What is Receivable Turnover Ratio?
What is Pro Dex Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PDEX Receivables Turnover Ratio	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter	(Jun 30 2025) IV. Quarter
Y / Y Receivable Change	29.04 %	22.77 %	18.33 %	35.51 %	18.33 %
Y / Y Revenue Change	16.65 %	14.56 %	11.14 %	24.43 %	16.43 %
Receivable Turnover Ratio (TTM)	4.12	4.23	4.31	4.36	4.47
PDEX's Total Ranking	# 740	# 161	# 657	# 629	# 2550
Accounts Receivable average collection period days	89	86	85	84	82
Seq. Receivable Change	8.89 %	18.5 %	-9.88 %	10.96 %	3.61 %
Seq. Revenue Change	2.29 %	6.89 %	0.72 %	5.92 %	0.46 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 34
Healthcare Sector	# 78
Overall Market	# 740

Receivable Turnover Ratio Statistics
High	Average	Low
1.84	1.15	0.92
(Sep 30 2016)		(Mar 31 2022)

PDEX Company Profile • Back to PDEX Efficiency Comparisons • Compare PDEX Receivables Turnover Ratio to its Competitors

Financial Statements
Pro Dex Inc 's Accounts Receivable	$ 21 Millions	Visit PDEX's Balance sheet
Pro Dex Inc 's Sales TTM	$ 78 Millions	Visit PDEX's Income Statement
Sources of PDEX's Revenues		Visit PDEX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PDEX's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PDEX's Growth Rates	PDEX's Roa	PDEX's Inventory Turnover Ratio	PDEX's Dividend Comparisons
PDEX's Profitability Ratios	PDEX's Roi	PDEX's Asset Turnover Ratio	PDEX's Dividend Growth
PDEX's Valuation Ratios	PDEX's Roe	PDEX's Financial Strength Ratios	PDEX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Kestra Medical Technologies Ltd	10.00	$ 105.939 Millions	$ 10.590 Millions
United Therapeutics Corporation	9.93	$ 3,154.500 Millions	$ 317.550 Millions
Utah Medical Products Inc	9.88	$ 35.679 Millions	$ 3.612 Millions
Biolife Solutions Inc	9.67	$ 102.718 Millions	$ 10.626 Millions
The Oncology Institute Inc	9.66	$ 587.244 Millions	$ 60.780 Millions
Sharps Technology Inc	9.65	$ 1.960 Millions	$ 0.203 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
Septerna Inc	9.42	$ 98.882 Millions	$ 10.501 Millions
Biofrontera Inc	9.33	$ 45.956 Millions	$ 4.928 Millions
Enanta Pharmaceuticals Inc	9.29	$ 65.258 Millions	$ 7.027 Millions
The Pennant Group Inc	9.27	$ 1,101.710 Millions	$ 118.798 Millions
Crinetics Pharmaceuticals Inc	9.25	$ 42.156 Millions	$ 4.558 Millions
Neuronetics Inc	9.24	$ 154.594 Millions	$ 16.732 Millions
Myomo Inc	9.24	$ 44.242 Millions	$ 4.790 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Bioaffinity Technologies Inc	9.18	$ 5.901 Millions	$ 0.643 Millions
Pavmed Inc	9.16	$ 0.126 Millions	$ 0.014 Millions
Clene Inc	9.16	$ 0.197 Millions	$ 0.022 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions
Lexicon Pharmaceuticals Inc	9.14	$ 41.469 Millions	$ 4.535 Millions
Novavax inc	9.06	$ 413.796 Millions	$ 45.668 Millions
Nuvation Bio Inc	9.05	$ 169.551 Millions	$ 18.737 Millions
Cue Biopharma Inc	9.04	$ 37.654 Millions	$ 4.165 Millions
Sunshine Biopharma Inc	9.03	$ 35.347 Millions	$ 3.916 Millions
Biocryst Pharmaceuticals Inc	9.00	$ 940.613 Millions	$ 104.543 Millions
Edwards Lifesciences Corporation	8.99	$ 6,512.500 Millions	$ 724.750 Millions
Cannapharmarx Inc	8.86	$ 1.699 Millions	$ 0.192 Millions
Grail Inc	8.85	$ 165.263 Millions	$ 18.670 Millions
Guardant Health Inc	8.84	$ 1,183.105 Millions	$ 133.772 Millions
Zomedica Corp	8.84	$ 35.903 Millions	$ 4.063 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.